Dr. Sieweke’s research focuses on stem cells and the immune system. Only recently his group showed that hematopoietic stem cells do not merely ensure the continuous renewal of our blood cells; in emergencies they are capable of producing white blood cells “on demand” that help the body deal with inflammation or infection. This discovery could be used to protect against infections in patients undergoing bone marrow transplants, while their immune system reconstitutes itself.
Dr. Sieweke studied Biochemistry in Tübingen, Germany and at the University of California in Berkeley, USA, and completed his postdoctoral qualification (Habilitation) at the University of Heidelberg, Germany in 1999. He worked at the European Molecular Biology Laboratory (EMBL) in Heidelberg and since 1999 has been a researcher in Marseille. He has received numerous prestigious fellowships.
Including Dr. Sieweke, nine scientists from the MDC are members of EMBO: Professor Carmen Birchmeier, Professor Walter Birchmeier, Professor Thomas Jentsch (also Leibniz-Institut für Molekulare Pharmakologie, FMP), Professor Achim Leutz, Professor Gary Lewin, Professor Klaus Rajewsky, Professor Nikolaus Rajewsky and Professor Thomas Sommer.
*CIML/INSERM/CNRS
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Contact:
Barbara Bachtler
Press Department
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Robert-Rössle-Straße 10
13125 Berlin
Germany
Phone: +49 (0) 30 94 06 – 38 96
Fax: +49 (0) 30 94 06 – 38 33
e-mail: presse@mdc-berlin.de
http://www.mdc-berlin.de/